Clinical Trial

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

Study acronym: GANNON
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this trial is to evaluate the safety of the HistoSonics Edison System for the destruction of pancreatic adenocarcinomas using histotripsy.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-08 -> 2028-03 2026-07-10
minor Completion pushed: 2027-01 -> 2028-08 2026-07-10
Trial Details
NCT Number NCT06282809
Lead Sponsor HistoSonics, Inc.
Conditions Pancreas Cancer, Adenocarcinoma of the Pancreas, Pancreatic Cancer, Tumor of Pancreas
Enrollment 50 participants
Start Date 2024-12-10
Primary Completion 2028-03 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-09